Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Deferasirox Patent Expiration

Deferasirox is used for treating allergies and allergic reactions. It was first introduced by Novartis Pharmaceuticals Corp in its drug Exjade on Nov 2, 2005. Other drugs containing Deferasirox are Jadenu Sprinkle, Jadenu. 20 different companies have introduced drugs containing Deferasirox.


Deferasirox Patents

Given below is the list of patents protecting Deferasirox, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Jadenu US9283209 Oral formulations of deferasirox Nov 21, 2034 Novartis Pharms Corp
Exjade US6465504 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Apr 05, 2019

(Expired)

 Novartis
Jadenu US6465504 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Apr 05, 2019

(Expired)

 Novartis Pharms Corp
Jadenu Sprinkle US6465504 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Apr 05, 2019

(Expired)

 Novartis
Exjade US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Jun 24, 2017

(Expired)

 Novartis
Jadenu US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Jun 24, 2017

(Expired)

 Novartis Pharms Corp



Deferasirox's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Deferasirox Generic API Manufacturers

Several generic applications have been filed for Deferasirox. The first generic version for Deferasirox was by Actavis Elizabeth Llc and was approved on Jan 26, 2016. And the latest generic version is by Norvium Bioscience Llc and was approved on May 17, 2024.

Given below is the list of companies who have filed for Deferasirox generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet, for suspension Prescription ORAL AB Jan 26, 2016
125MG

tablet, for suspension Prescription ORAL AB Jan 26, 2016
500MG

tablet, for suspension Prescription ORAL AB Jan 26, 2016
360MG

tablet Prescription ORAL AB Dec 13, 2019
90MG

tablet Prescription ORAL AB Dec 13, 2019
180MG

tablet Prescription ORAL AB Dec 13, 2019


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





2. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
360MG

tablet Prescription ORAL AB Nov 20, 2019
90MG

tablet Prescription ORAL AB Nov 20, 2019
180MG

tablet Prescription ORAL AB Jun 15, 2020


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Vadodara Alembic Pharmaceuticals, Ltd
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited





3. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
360MG

granule Prescription ORAL AB Jul 14, 2020
90MG

granule Prescription ORAL AB Jul 14, 2020
180MG

granule Prescription ORAL AB Jul 14, 2020





4. AMNEAL

Amneal Eu Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
180MG

granule Discontinued ORAL N/A Feb 9, 2021
360MG

granule Discontinued ORAL N/A Feb 9, 2021
90MG

granule Discontinued ORAL N/A Aug 2, 2021


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Glasgow Amneal Pharmaceuticals LLC
East Hanover Amneal Pharmaceuticals LLC
Branchburg Amneal Pharmaceuticals, LLC
Piscataway Amneal Pharmaceuticals, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Paterson Amneal Pharmaceuticals, Llc
Brookhaven Amneal Pharmaceuticals of New York, LLC
Bridgewater Amneal Complex Products Research LLC
India
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.
Hyderabad Amneal Oncology Private Limited
Ahmedabad Amneal Pharmaceuticals Private Ltd.





5. ANNORA PHARMA

Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Annora Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG

granule Prescription ORAL AB Sep 22, 2022
90MG

granule Prescription ORAL AB Mar 16, 2023
180MG

granule Prescription ORAL AB Sep 22, 2022


Manufacturing Plant Locations
New

Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.

Country City Firm Name
India
Hyderabad Annora Pharma Private Limited





6. AUCTA

Aucta Pharmaceuticals Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Aucta.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG

granule Prescription ORAL AB Mar 9, 2021
360MG

granule Prescription ORAL AB Mar 9, 2021
180MG

granule Prescription ORAL AB Mar 9, 2021





7. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
180MG

tablet Prescription ORAL AB Oct 16, 2023
90MG

tablet Prescription ORAL AB Oct 16, 2023
360MG

tablet Prescription ORAL AB Oct 16, 2023


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





8. BIONPHARMA

Bionpharma Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





9. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG

tablet Prescription ORAL AB May 27, 2021
180MG

tablet Prescription ORAL AB May 27, 2021
90MG

tablet Prescription ORAL AB May 27, 2021





10. CIPLA

Cipla Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG

granule Prescription ORAL AB Feb 23, 2022
360MG

granule Prescription ORAL AB Feb 23, 2022
180MG

granule Prescription ORAL AB Feb 23, 2022


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Pithampur, District Dhar Cipla Limited
Raigad Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Bengaluru Cipla Limited
Bangalore Cipla Ltd.
Mumbai Cipla Limited
Vasco Da Gama Cipla Limited





11. GLENMARK SPECLT

Glenmark Specialty Sa has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

tablet, for suspension Prescription ORAL AB Jan 6, 2020
250MG

tablet, for suspension Prescription ORAL AB Jan 6, 2020
125MG

tablet, for suspension Prescription ORAL AB Jan 6, 2020





12. MSN

Msn Laboratories Private Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG

granule Prescription ORAL AB Apr 20, 2022
500MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
360MG

granule Prescription ORAL AB Mar 17, 2021
180MG

granule Prescription ORAL AB Mar 17, 2021


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Rangareddy District MSN Laboratories Private Limited
Sangareddy MSN Pharmachem Private Limited
Yadadri Bhuvanagiri District MSN Organics Private Limited
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Isnapur MSN Laboratories Private Limited, Unit-II
Sangareddy MSN Laboratories Private Limited, R&D Center
Sangareddy MSN Laboratories Private Ltd.
Kamareddy MSN Life Sciences Private Limited
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
United States
Piscataway MSN PHARMACEUTICALS INC





13. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
180MG

granule Discontinued ORAL N/A May 3, 2024
360MG

granule Discontinued ORAL N/A May 3, 2024
90MG

granule Discontinued ORAL N/A May 3, 2024
250MG

tablet, for suspension Discontinued ORAL N/A May 17, 2024
125MG

tablet, for suspension Discontinued ORAL N/A May 17, 2024
500MG

tablet, for suspension Discontinued ORAL N/A May 17, 2024





14. PIRAMAL

Piramal Healthcare Uk Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Piramal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG

tablet Prescription ORAL AB Dec 30, 2019
360MG

tablet Prescription ORAL AB Dec 30, 2019
180MG

tablet Prescription ORAL AB Jun 15, 2020





15. STEVENS J

Jerome Stevens Pharmaceuticals Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Stevens J.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG

tablet Discontinued ORAL N/A Dec 27, 2019
360MG

tablet Discontinued ORAL N/A Dec 27, 2019
180MG

tablet Discontinued ORAL N/A Jun 15, 2020





16. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
500MG

tablet, for suspension Prescription ORAL AB Nov 20, 2019
90MG

tablet Prescription ORAL AB Jan 2, 2020
360MG

tablet Prescription ORAL AB Jan 2, 2020
180MG

tablet Prescription ORAL AB Jun 15, 2020


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Billerica Sun Pharmaceutical Industries, Inc.
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
India
Mohali Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd
Bharuch Sun Pharmaceutical Industries Ltd
Baruch Sun Pharmaceutical Industries Ltd.
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Vadodara Sun Pharmaceutical Industries Ltd.
Punjab Sun Pharmaceutical Industries, Inc.
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Dadra Sun Pharmaceutical Industries Limited
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited





17. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG

granule Prescription ORAL AB Nov 19, 2021
90MG

granule Prescription ORAL AB Nov 19, 2021
180MG

granule Prescription ORAL AB Nov 19, 2021
250MG

tablet, for suspension Prescription ORAL AB Sep 23, 2022
500MG

tablet, for suspension Prescription ORAL AB Sep 23, 2022
125MG

tablet, for suspension Prescription ORAL AB Sep 23, 2022





18. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG

tablet Prescription ORAL AB Nov 20, 2019
90MG

tablet Prescription ORAL AB Nov 20, 2019
500MG

tablet, for suspension Discontinued ORAL N/A May 5, 2020
125MG

tablet, for suspension Discontinued ORAL N/A May 5, 2020
250MG

tablet, for suspension Discontinued ORAL N/A May 5, 2020
180MG

tablet Prescription ORAL AB Jun 15, 2020